Search research articles
Contact Us
Filters
Showing results (61-70 of 159) with videos related to
Page
of 16
Sort By:
Frontiers in Oncology
|
October 20, 2022
Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review
Jeffrey Y C Wong, An Liu, Chunhui Han, et al.
Cancer Chemotherapy and Pharmacology
|
January 12, 2010
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
Peter M Wilson, Anthony El-Khoueiry, Syma Iqbal, et al.
Cancer
|
February 19, 2015
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases
Stefan Stremitzer, Wu Zhang, Dongyun Yang, et al.
International Journal of Cancer
|
July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning, Philipp C Manegold, Young Kwon Hong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial
Mitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
Anticancer Research
|
November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)
Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.
Pharmacogenomics
|
December 19, 2007
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients
Mizutomo Azuma, Michael Shi, Kathleen D Danenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2016
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy
Satoshi Matsusaka, Diana L Hanna, Shu Cao, et al.
Clinical Colorectal Cancer
|
August 16, 2005
Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer
Wu Zhang, Jan Stoehlmacher, David J Park, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
December 17, 2019
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia
Jason Chen, Justine Abella Ross, Bernard Tegtmeier, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 159) with videos related to
Sort By:
Page
of 16
Frontiers in Oncology
|
October 20, 2022
Total marrow irradiation (TMI): Addressing an unmet need in hematopoietic cell transplantation - a single institution experience review
Jeffrey Y C Wong, An Liu, Chunhui Han, et al.
Cancer Chemotherapy and Pharmacology
|
January 12, 2010
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
Peter M Wilson, Anthony El-Khoueiry, Syma Iqbal, et al.
Cancer
|
February 19, 2015
Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases
Stefan Stremitzer, Wu Zhang, Dongyun Yang, et al.
International Journal of Cancer
|
July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning, Philipp C Manegold, Young Kwon Hong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2018
Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial
Mitsukuni Suenaga, Sebastian Stintzing, Shu Cao, et al.
Anticancer Research
|
November 2, 2010
Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study)
Wu Zhang, Mizutomo Azuma, Georg Lurje, et al.
Pharmacogenomics
|
December 19, 2007
Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients
Mizutomo Azuma, Michael Shi, Kathleen D Danenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 4, 2016
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy
Satoshi Matsusaka, Diana L Hanna, Shu Cao, et al.
Clinical Colorectal Cancer
|
August 16, 2005
Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer
Wu Zhang, Jan Stoehlmacher, David J Park, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
December 17, 2019
Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia
Jason Chen, Justine Abella Ross, Bernard Tegtmeier, et al.
Page
of 16